Back to top of page

NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)

To apply for the NHLBI Emerging Investigator Award (EIA), applicants will need to provide the following information:

1. Name of the Program Director/Principal Investigator (PD/PI) who will be the main recipient of the award.

2. Current active NHLBI R01-equivalent grants on which the PD/PI is listed as the primary investigator.

3. Description of the PD/PI's outstanding record of research and demonstrated ability to make major contributions to heart, lung, blood, and sleep (HLBS) research.

4. Description of the research program that will be supported by the EIA, including the goals, objectives, and overall impact on the field of HLBS research.

5. Plan for how the EIA funds will be allocated and used in the research program.

6. Justification for why the EIA is necessary and how it will provide increased flexibility and long-term support for the PD/PI's research.

7. Explanation of how the EIA will enable the PD/PI to break new ground, extend previous discoveries, take greater risks, and pursue research with a longer timeframe.

8. Assurance that the research supported by the EIA will be within the scope of the NHLBI mission.

9. Budget proposal detailing the anticipated costs and funding needs for the research program.

10. Any additional supporting documentation, such as letters of recommendation or collaboration agreements, that may strengthen the application.

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows